Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
Provided By GlobeNewswire
Last update: Aug 6, 2025
Revenue grew 32% year-over-year, driven by increased product sales and service revenue
Launched new high-throughput Proteograph® ONE assay and SP200 automation instrument
Read more at globenewswire.comNASDAQ:SEER (12/5/2025, 3:51:03 PM)
1.88
-0.04 (-2.08%)
Find more stocks in the Stock Screener
